Skip to main content

DayOne Accelerator finalizes participants

| News

DayOne Accelerator finalizes participants

20.11.2019

BaselArea.swiss manages the DayOne initiative, which is now organizing the second round of the DayOne Accelerator. The participants are Digital Health startups promoting the health of children and young people.

DayOne Conference 2019

The DayOne Accelerator has chosen six participants, of whom four will receive non-dilutive funding of 50,000 Swiss francs, announced a statement. All the participants will benefit from BaselArea.swiss, which is providing support by connecting them to a network of potential partners and customers, including the particularly distinguished University Children’s Hospital Basel (UKBB).

A total of 120 startups applied to the competition, and 14 were shortlisted. These companies worked in part with UKBB to develop their business ideas, before six were chosen by a panel of experts from the region to progress to the accelerator. One of the participants is the Basel company Nutrix, which is developing a nanosensor for glucose monitoring in saliva to prevent diabetes. Virtual Doctors is another – a telemedicine company that supports healthcare professionals who provide care in Zambia.

The four companies that will receive a place on the program and financial support include the Basel company Zoundream , whose goal is to help identify the messages and potential pathologies in babies’ crying. Another is Haako, also Basel-headquartered, which is helping parents of children with asthma to better manage their condition. Rekonas (e Tomo), a spinoff from the University of Basel, is working on improved bedside monitoring of epilepsy. Finally, Wello Health is a Romanian company that helps families with overweight children to improve nutrition.

During the six-month program, the participants will learn from the accelerator – but the organizers will in turn learn from the startups’ developments, according to Fabian Streiff, Director Healthcare Innovation – DayOne at BaselArea.swiss. He said: “We understand that the process of taking a venture from a good idea to a viable venture in digital health is challenging and that these entrepreneurs need support.”

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.